Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Dramatic improvement in Down syndrome-associated cognitive impairment with donepezil.

Kondoh T, Amamoto N, Doi T, Hamada H, Ogawa Y, Nakashima M, Sasaki H, Aikawa K, Tanaka T, Aoki M, Harada J, Moriuchi H.

Ann Pharmacother. 2005 Mar;39(3):563-6. Epub 2005 Feb 8.

PMID:
15701776
2.

Donepezil use in the treatment of dementia associated with Down syndrome.

Cipriani G, Bianchetti A, Trabucchi M.

Arch Neurol. 2003 Feb;60(2):292; author reply 292. No abstract available.

PMID:
12580720
3.

Effects of donepezil on cognitive functioning in Down syndrome.

Johnson N, Fahey C, Chicoine B, Chong G, Gitelman D.

Am J Ment Retard. 2003 Nov;108(6):367-72.

PMID:
14561111
4.

[Clinical-therapeutic study of dementia in people with Down syndrome and the effectiveness of donepezil in this population].

Boada-Rovira M, Hernández-Ruiz I, Badenas-Homiar S, Buendía-Torras M, Tárraga-Mestre L.

Rev Neurol. 2005 Aug 1-15;41(3):129-36. Spanish.

5.

Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10-17.

Kishnani PS, Heller JH, Spiridigliozzi GA, Lott I, Escobar L, Richardson S, Zhang R, McRae T.

Am J Med Genet A. 2010 Dec;152A(12):3028-35. doi: 10.1002/ajmg.a.33730.

PMID:
21108390
6.

Preliminary study of the safety and efficacy of donepezil hydrochloride in children with Down syndrome: a clinical report series.

Spiridigliozzi GA, Heller JH, Crissman BG, Sullivan-Saarela JA, Eells R, Dawson D, Li J, Kishnani PS.

Am J Med Genet A. 2007 Jul 1;143A(13):1408-13.

PMID:
17542008
7.

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study.

Prasher VP, Adams C, Holder R; Down Syndrome Research Group.

Int J Geriatr Psychiatry. 2003 Jun;18(6):549-51. No abstract available.

PMID:
12789681
8.

Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.

Rao NP, Palaniyappan P, Chandur J, Venkatasubramanian G, Gangadhar BN.

J ECT. 2009 Sep;25(3):216-8. doi: 10.1097/YCT.0b013e3181926ada.

PMID:
19190508
9.

Efficacy and tolerability of low-dose donepezil in schizophrenia.

Erickson SK, Schwarzkopf SB, Palumbo D, Badgley-Fleeman J, Smirnow AM, Light GA.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):179-84.

PMID:
16062097
10.

[Extra-pyramidal syndrome induced by donepezil].

Carcenac D, Martin-Hunyadi C, Kiesmann M, Demuynck-Roegel C, Alt M, Kuntzmann F.

Presse Med. 2000 May 20;29(18):992-3. French.

PMID:
10862247
11.

Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life.

Shaw EG, Rosdhal R, D'Agostino RB Jr, Lovato J, Naughton MJ, Robbins ME, Rapp SR.

J Clin Oncol. 2006 Mar 20;24(9):1415-20.

12.

[Donepezil therapy in patients with vascular and post-traumatic cognitive impairment: some clinical observations].

Olazarán-Rodríguez J, Cruz-Orduña I, Jiménez-Martín I.

Rev Neurol. 2004 May 16-31;38(10):938-43. Spanish.

13.

A randomized, double-blind, placebo-controlled trial of donepezil to improve memory in epilepsy.

Hamberger MJ, Palmese CA, Scarmeas N, Weintraub D, Choi H, Hirsch LJ.

Epilepsia. 2007 Jul;48(7):1283-91. Epub 2007 May 1.

14.

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T.

J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9.

15.

Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders.

Cummings JL, McRae T, Zhang R; Donepezil-Sertraline Study Group.

Am J Geriatr Psychiatry. 2006 Jul;14(7):605-12.

PMID:
16816014
16.

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial.

Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM; Donepezil MSAD Study Investigators Group.

Int J Geriatr Psychiatry. 2005 Jun;20(6):559-69.

PMID:
15920715
17.

A systematic review of the clinical effectiveness of donepezil, rivastigmine and galantamine on cognition, quality of life and adverse events in Alzheimer's disease.

Takeda A, Loveman E, Clegg A, Kirby J, Picot J, Payne E, Green C.

Int J Geriatr Psychiatry. 2006 Jan;21(1):17-28. Review.

PMID:
16323253
18.

A case of Korsakoff's syndrome improved by high doses of donepezil.

Iga JI, Araki M, Ishimoto Y, Ohmori T.

Alcohol Alcohol. 2001 Nov-Dec;36(6):553-5.

19.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
20.

Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.

Fagerlund B, Søholm B, Fink-Jensen A, Lublin H, Glenthøj BY.

Clin Neuropharmacol. 2007 Jan-Feb;30(1):3-12.

PMID:
17272964
Items per page

Supplemental Content

Write to the Help Desk